Where does GenomeDx Biosciences Inc. rank among US patent assignees?

According to USPTO PatentsView (2015–2025 granted utility patents), GenomeDx Biosciences Inc. ranks #40,401 of 49,997 assignees by granted-patent volume, the same sort as the companies listing and top-holders ranking. See /methodology/#corpus-placement.

How many patents does GenomeDx Biosciences Inc. hold?

GenomeDx Biosciences Inc. holds 6 US utility patents granted between 2015 and 2019, spanning 3 technology areas.

What is GenomeDx Biosciences Inc.'s Innovation Score?

GenomeDx Biosciences Inc. has an Innovation Score of 21.4 out of 100 (8th percentile of the corpus). This composite metric weighs portfolio volume (40%), grant velocity (20%), technology breadth (25%), and claim depth (15%).

Is GenomeDx Biosciences Inc.'s patent grant rate increasing or decreasing?

GenomeDx Biosciences Inc.'s recent grant velocity is -100% compared to the prior five-year period (grant years, not application filing dates). Grant activity has slowed relative to earlier years.

What does claim depth mean for GenomeDx Biosciences Inc.'s patents?

GenomeDx Biosciences Inc.'s patents average 14.3 claims each. This is an aggregate descriptive count from the grant record; it does not establish claim scope, legal strength, enforceability, or design-around risk.

How is the GenomeDx Biosciences Inc. patent data sourced?

All patent data comes from USPTO PatentsView, a public research dataset maintained by the United States Patent and Trademark Office covering US granted utility patents from 2015 to 2025.

USPTO 2015–2025 USPTO PatentsView Foreign Corporation

GenomeDx Biosciences Inc.

Q: What technology areas does GenomeDx Biosciences Inc. focus on?

GenomeDx Biosciences Inc.'s top technology area is C12Q (Measuring OR Testing Processes Involving Enzymes, Nucleic Acids OR Microorganisms ; Compositions OR Test Papers THEREFOR; Processes OF Preparing Such COMPOSITIONS; Condition-responsive Control IN Microbiological OR Enzymological Processes) with 6 patents, ranking #717 of 2,502 assignees active in that subclass. Grants appear in 3 CPC subclasses total.

USPTO PatentsView assignee record - 6 granted patents across 3 technology areas, recorded in grant years 2015–2019. Grant-trend analysis is cross-referenced to USPTO Patent Public Search; it does not measure application filings, current R&D, or legal strength. Primary class: C12Q (Measuring OR Testing Processes Involving Enzymes, Nucleic Acids OR Microorganisms ; Compositions OR Test Papers THEREFOR; Processes OF Preparing Such COMPOSITIONS; Condition-responsive Control IN Micr).

Compiled by PlainPatent · May 15, 2026

RSS updates for this company

Explore the portfolio See the ranking

The verdict

According to USPTO PatentsView, Genomedx ranks #40,401 of 49,997 tracked US assignees by granted-patent volume, with 6 patents across 3 technology areas.

#40,401
of 49,997 US assignees by volume: 8th percentile
by Innovation Score (21.4/100): 14.3
avg claims per patent: -100%
grant velocity, last 5 yrs

USPTO PatentsView assignee plate

Corpus R40401 · Foreign Corporation #40,401 · 6 grants

GRANTS-MICRO · LOWER-Q · PHOTO-FINISH · CPC-NARROW · INNOV-THIN · CLAIMS-RICH · TYPE-FRNCORP · VEL-DROP · BOOK-FULL

GRANTS-MICRO 6 grants
LOWER-Q #40,401/49,997
PHOTO-FINISH General Scientific…
CPC-NARROW C12Q · 3 areas
INNOV-THIN 21.4/100
CLAIMS-RICH 14.3 claims/avg
TYPE-FRNCORP Foreign Corp
VEL-DROP -100% vel
BOOK-FULL 10/10 fields

Nearest grant-volume peer: General Scientific Corporation/Surgitel (±0 grants)

Instrument codes from this assignee’s USPTO PatentsView grant sheet: volume band, corpus rank, photo-finish peer, lead CPC, Innovation Score, claim depth, assignee type, velocity, and book completeness. Not a USPTO rating of patent strength.

How Genomedx’s 21.4 Innovation Score adds up

The same four weighted components behind every Innovation Score on PlainPatent: portfolio volume, grant velocity, technology breadth, and claim depth.

Volume 6.7 pts (31%) Velocity 0.0 pts (0%) Breadth 6.1 pts (29%) Claim depth 8.6 pts (40%)

Qualcomm Incorporated · highest

85
GenomeDx Biosciences · this assignee

21
3D Lighting… · lowest

7

What this shows Genomedx's Innovation Score is 21.4/100 (8th percentile of the PatentsView-derived corpus). The chart places that score against the nearest Innovation Score peers plus corpus poles, not a reprint of the volume ranking.

Does more volume mean deeper claims for Genomedx?

Each dot is one of Genomedx’s 8 nearest volume peers (same corpus rank neighbourhood as the chart above), placed by total granted patents (horizontal) against average claims per patent (vertical). Genomedx’s own 14.3 claims/patent is at or below the 14.7 median for these volume peers. Volume here does not track with deeper claims; several lower-volume peers claim more thoroughly per patent.

Genomedx vs its 8 nearest volume peers: granted patents vs average claims per patent. Source: USPTO PatentsView.

Where Genomedx's grants concentrate

GenomeDx Biosciences Inc. is a focused PatentsView assignee: 3 CPC subclasses with 100% of grants classified under C12Q (Measuring OR Testing Processes Involving Enzymes, Nucleic Acids OR Microorganisms ; Compositions OR Test Papers THEREFOR; Processes OF Preparing Such COMPOSITIONS; Condition-responsive Control IN Micr). Peak complete grant year is 2015 (2 grants) versus a trough of 1 in 2018. By volume, Genomedx sits between General Scientific Corporation/Surgitel and Georg Fischer Harvel LLC.

General Scientifi…

6
Genesis Attachmen…

6
Genimex Jersey

6
Genisphere

6
Geographic Soluti…

6
Geophysical Techn…

6
Georg Fischer & KG

6
Georg Fischer Har…

6
Genomedx Bioscien… ◀

6

What this shows GenomeDx holds 6 patents at rank #40,484, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.

Companies ranked near GenomeDx

By rank, the assignees closest to #40,484 in granted patent volume.

Leaders in C12Q (Measuring OR Testing Processes Involving Enzymes)

Other assignees with the most granted patents in GenomeDx's primary technology class.

Genomedx's Innovation Score vs. every tracked assignee

Composite of portfolio volume, grant velocity, technology breadth, and claim depth (0–100)

21 8th percentile higher than 8% of 49,997 US assignees

Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025

USPTO utility patent grants by year · 2015–2019

Grants by year

Teal-shaded recent years (2020–present) versus the 2015–2019 baseline. Full figures in the table below.

View data table

GenomeDx Biosciences Inc. patent grants by year, 2015–2025
Year	Patents Granted	Share of Period
2015	2	33.3%
2017	2	33.3%
2018	1	16.7%
2019	1	16.7%

Which technologies does GenomeDx Biosciences Inc. patent most?

C12Q - Measuring OR Testing Processes Involving Enzymes, Nucleic Acids OR Microorganisms ; Compositions OR Test Papers THEREFOR; Processes OF Preparing Such COMPOSITIONS; Condition-responsive Control IN Microbiological OR Enzymological Processes 6

Y02A - Technologies FOR Adaptation TO Climate Change 3

C40B - Combinatorial CHEMISTRY; Libraries, e.g. Chemical Libraries 3

Top 3 of 3 technology areas

More on this record

Data Source

USPTO PatentsView, US granted patents 2015–2025

View all rankings → How is Innovation Score calculated?

What to do with this data

GenomeDx Biosciences Inc.'s patent record in context - here's where to go next.

GenomeDx Biosciences Inc.'s lead technology class is C12Q (Measuring OR Testing Processes Involving Enzymes, Nucleic Acids OR Microorganisms ; Compositions OR Test Papers THEREFOR; Processes OF Preparing Such COMPOSITIONS; Condition-responsive Control IN Micr), 100% of its portfolio - see every assignee active in that class. Explore C12Q
Ranked #40,401 of 49,997 tracked assignees by patent volume - see the full leaderboard. See the ranking
Compare GenomeDx Biosciences Inc. against General Scientific Corporation/Surgitel, an assignee filing at a similar volume. Compare portfolios
Innovation Score of 21.4/100 blends volume, velocity, technology breadth, and claim depth. How it's calculated

Figures reflect USPTO PatentsView grant data through May 2026; pending applications not yet granted are not counted.

Data sourced from USPTO PatentsView - official U.S. government patent data. See our methodology for computation details. Retrieved and formatted by PlainPatent

Disclaimer: This information is provided for informational purposes only and does not constitute professional advice. Data is sourced from the USPTO PatentsView database. Consult a qualified professional before making decisions based on this data.

Read our methodology - how this data is sourced, computed, and verified.

Data sources used on this page

USPTO PatentsView - the disambiguated bulk patent-grant, assignee, and CPC data this page's figures are derived from. patentsview.org
Cooperative Patent Classification (CPC) - the joint USPTO/EPO classification scheme used to group patents by technology area. cooperativepatentclassification.org
USPTO Patent Public Search - the official interface to verify the status of any individual patent. ppubs.uspto.gov

Compiled by PlainPatent , US Patent Intelligence Editorial Process · May 15, 2026

Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.